# Arvee Laboratories (India) (NSE: ARVEE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ARVEE · Pivot · prices to 22 Oct 2026

Arvee Laboratories (India) (NSE: ARVEE) closed at ₹199.29 on 22 Oct 2026, down 2.45% on the day. With a market capitalisation of ₹220 Cr, it ranks 2210th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Specialty Chemicals.

At its last close the stock traded at 106× trailing earnings, against a return on equity of 6.9% in FY25. Over the past year the share price has risen 23.0%. Its 52-week range is ₹129.11 (30 Mar 2026) to ₹290.78 (19 Dec 2025); the last close is 31.5% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹11 Cr (+67.4% year on year) and net profit ₹1 Cr (+642.9%), on a standalone basis. Promoters held 73.50% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹199.29 |
| Market cap | ₹220 Cr |
| P/E (trailing) | 106 |
| ROE | 6.9% (FY25) |
| ROCE | 9.2% (FY25) |
| Debt to equity | 0.03 |
| 52-week high | ₹290.78 (19 Dec 2025) |
| 52-week low | ₹129.11 (30 Mar 2026) |
| 1-year return | +23.0% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹11 Cr | +67.4% | ₹1 Cr | +642.9% | ₹0.47 |
| Q3 FY26 | ₹10 Cr | +9.8% | ₹2 Cr | +1,120.0% | ₹1.66 |
| Q2 FY26 | ₹3 Cr | −72.5% | ₹0 Cr | −99.0% | ₹0.01 |
| Q1 FY26 | ₹7 Cr | −29.4% | ₹0 Cr | −81.9% | ₹0.15 |
| Q4 FY25 | ₹6 Cr | +5.0% | ₹0 Cr | −41.7% | ₹0.06 |
| Q3 FY25 | ₹9 Cr | +15.7% | ₹0 Cr | −37.5% | ₹0.14 |
| Q2 FY25 | ₹13 Cr | +40.6% | ₹1 Cr | +366.7% | ₹0.89 |
| Q1 FY25 | ₹11 Cr | +39.5% | ₹1 Cr | +91.8% | ₹0.85 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹38 Cr | ₹2 Cr |
| FY24 | ₹30 Cr | ₹1 Cr |
| FY23 | ₹61 Cr | ₹4 Cr |
| FY22 | ₹40 Cr | ₹3 Cr |
| FY21 | ₹47 Cr | ₹3 Cr |
| FY20 | ₹45 Cr | ₹2 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 73.50%
- Non-institutions: 26.50%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Chembond Material Technologies](https://app.pivotnow.in/stock/CHEMBOND) | ₹175.64 | ₹236 Cr | 18.3 | — |
| [Sikko Industries](https://app.pivotnow.in/stock/SIKKO) | ₹5.19 | ₹227 Cr | 43.3 | — |
| [Multibase India](https://app.pivotnow.in/stock/MULTIBASE) | — | ₹225 Cr | — | — |
| [Indag Rubber](https://app.pivotnow.in/stock/INDAG) | — | ₹223 Cr | — | — |
| [S V J Enterpris](https://app.pivotnow.in/stock/SVJ) | — | ₹219 Cr | — | — |
| [Gourmet Gateway](https://app.pivotnow.in/stock/GOURMET) | — | ₹214 Cr | — | — |

## Questions and answers

### What is the share price of Arvee Laboratories (India) today?

Arvee Laboratories (India) (NSE: ARVEE) last closed at ₹199.29 on 22 Oct 2026. Its 52-week high is ₹290.78 and its 52-week low is ₹129.11.

### What is the market cap of Arvee Laboratories (India)?

Arvee Laboratories (India)'s market capitalisation is ₹220 Cr (₹220 Cr) at the 22 Oct 2026 close, ranking 2210th among the NSE companies Pivot tracks.

### What is the P/E ratio of Arvee Laboratories (India)?

Arvee Laboratories (India) trades at a trailing P/E of 106.

### What is the ROE and ROCE of Arvee Laboratories (India)?

Return on equity was 6.9% in FY25 and return on capital employed was 9.2% in FY25 (standalone figures).

### Is Arvee Laboratories (India) a debt-free company?

Arvee Laboratories (India) is close to debt-free: its debt-to-equity ratio was 0.03 in FY25.

### What were Arvee Laboratories (India)'s latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Arvee Laboratories (India) reported revenue of ₹11 Cr, +67.4% year on year, and net profit of ₹1 Cr, +642.9% year on year.

### How has Arvee Laboratories (India) stock performed over the last year?

Arvee Laboratories (India)'s share price has risen 23.0% over the past year, +28.6% over three months and −4.6% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Arvee Laboratories (India)?

As of 30 Jun 2026: promoters 73.50%, non-institutions 26.50%.

### Who are Arvee Laboratories (India)'s competitors?

The listed Cement & Materials companies closest to Arvee Laboratories (India) by market cap are Chembond Material Technologies, Sikko Industries, Multibase India, Indag Rubber, S V J Enterpris and Gourmet Gateway.

### Is Arvee Laboratories (India) a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Arvee Laboratories (India)'s price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ARVEE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.